APA (7th ed.) Citation

Lim, S. H., Lee, K., Kim, J., Im, H., Kim, I., Han, H. S., . . . Rha, S. Y. (2024, February). Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: A Korean, multicenter study (KCSG ST22-06). BMC Cancer.

Chicago Style (17th ed.) Citation

Lim, Sung Hee, et al. "Real-world Outcomes of Third-line Immune Checkpoint Inhibitors Versus Irinotecan-based Chemotherapy in Patients with Advanced Gastric Cancer: A Korean, Multicenter Study (KCSG ST22-06)." BMC Cancer Feb. 2024.

MLA (9th ed.) Citation

Lim, Sung Hee, et al. "Real-world Outcomes of Third-line Immune Checkpoint Inhibitors Versus Irinotecan-based Chemotherapy in Patients with Advanced Gastric Cancer: A Korean, Multicenter Study (KCSG ST22-06)." BMC Cancer, Feb. 2024.